FindTrial
Sign In

Hypertrophic cardiomyopathy means abnormal thickening of the heart muscle .Its very important to assess Right heart muscle function for better prognosis .In which we do heart scan and assess regional and global parameters evaluation of right ventricle .

Assessment of right ventricular function by echocardiography in patients with hypertrophic cardiomyopathy - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084362
Enrollment
34
Registered
2025-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I422- Other hypertrophic cardiomyopathy

Interventions

None listed

Sponsors

ROSHNI CAROL GONSALVES
Lead Sponsor
self sponsor
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Hypertrophic cardiomyopathy patients with obstructive or non obstructive types

Exclusion criteria

Exclusion criteria: 1.Post septal myectomy patients 2.valvular heart diseases 3.pericardial diseases 4.Hypertensive heart disease more than 2 medications 5.other cardiomyopthy

Design outcomes

Primary

MeasureTime frame
To assess the right ventricular function by echocardiography in patients with hypertrophic cardiomyopathy . This study will indicate whether Right ventricular function is good or badTimepoint: 6 months—

Secondary

MeasureTime frame
To assess RV function by 2D echocardiography , M-mode and speckle tracking in hypertrophic cardiomyopathy patientsTimepoint: 6 months—

Countries

India

Contacts

Public ContactRekha V

Manipal academy of higher education

rekha.v@manipal.edu9663682484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026